PTN — PALATIN TECHNOLOGIES INC
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 911216 ·
Last close
$10.10
Market Cap
$17.97M
52W High
$31.00
52W Low
$5.61
ADV30
110,467
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 3,920,675 | — | -1,580,994 | -1,432,987 | 13,225,337 | 10,159,494 | 2,633,459 |
| Dec 2025 | 116,036 | — | -7,328,548 | -7,263,861 | 17,927,728 | 14,476,162 | 6,461,709 |
| Sep 2025 | 8,847,550 | — | 4,661,053 | 4,677,534 | 8,614,660 | 1,273,083 | 8,218,261 |
| Jun 2025 | 0 | 0 | -4,602,654 | -2,229,798 | 3,266,954 | 2,564,265 | 8,043,999 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-14,932,332
Investing CF
$3,091,517
Financing CF
$21,993,063
CapEx
$-38,483
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-8.10
As of
2026-09-06
Balance + Analyst (yfinance extras)
Retained Earnings
$-463,093,213
Inventory
—
Receivables
$2,167,215
ST Investments
—
EBIT TTM
$-6,241,857
Pretax Income TTM
$-6,249,112
Interest Exp TTM
$7,255
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$12,884,261
EBITDA
$-8,752,423
Free Cash Flow
$-13,673,166
Enterprise Value
$11,122,687
Total Cash
$10,159,494
Total Debt
$286,662
Shares Out
1,779,275
Trailing EPS
$0.11
Book Value
$5.96
ROE
-297.2%
ROA
-65.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Jun 2025 | 0 | -22,707,839 | -17,307,349 | 3,266,954 | 8,043,999 | -4,777,045 | -21,306,637 |
| Jun 2024 | 4,490,090 | -30,277,965 | -29,736,113 | 10,742,266 | 10,853,763 | -111,497 | -31,461,441 |
| Jun 2023 | 4,853,678 | -33,486,205 | -24,036,741 | 17,939,440 | 19,919,311 | -1,979,871 | -29,271,346 |
| Jun 2022 | 1,468,457 | -36,588,448 | -36,198,299 | 36,070,794 | 19,802,919 | 16,267,875 | -29,922,749 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-2.43
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BFRI | Biofrontera Inc. | $17.53M | $1.18 | — |
| INTI | Inhibitor Therapeutics, Inc. | $17.48M | $0.10 | — |
| LPCN | Lipocine Inc. | $17.31M | $2.10 | — |
| ATOS | ATOSSA THERAPEUTICS, INC. | $18.96M | $1.90 | — |
| NCEL | NewcelX Ltd. | $17.02M | $2.95 | — |
News headlines (Yahoo Finance, 1h cache)
Palatin Reports Fiscal Year 2026 Financial Results and Provides Business Update
2026-09-28 11:30 · Yahoo
StreetWatch: A $2.9 Billion Takeover Put a Spotlight on Relentless Hunger. Palatin Technologies Is Developing the Next Generation of the Drug That Seeks to Treat It
2026-08-06 13:40 · Yahoo
Palatin Technologies, Inc. Q3 2026 Earnings Call Summary
2026-05-14 12:30 · Yahoo
Palatin Technologies Inc (PTN) Q3 2026 Earnings Call Highlights: Strategic Advances Amidst ...
2026-05-13 23:03 · Yahoo
Transcript: Palatin Techs Q3 2026 Earnings Conference Call
2026-05-13 15:31 · Yahoo
Palatin Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
2026-05-13 11:30 · Yahoo
Palatin to Begin Trading on Nasdaq Stock Exchange
2026-05-18 20:00 · Yahoo
Palatin Technologies, Inc. Q2 2026 Earnings Call Summary
2026-02-18 13:30 · Yahoo
Palatin Technologies Inc (PTN) Q2 2026 Earnings Call Highlights: Strategic Advances Amid Rising ...
2026-02-17 23:00 · Yahoo
Palatin Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update
2026-02-17 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.